⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13725728 | 1.00 | — | — | |
| SCHEMBL13839392 | 0.87 | — | — | |
| SCHEMBL13725935 | 0.87 | — | — | |
| SCHEMBL13725452 | 0.85 | — | — | |
| SCHEMBL13839391 | 0.85 | — | — | |
| SCHEMBL13725934 | 0.84 | — | — | |
| SCHEMBL13839390 | 0.84 | — | — | |
| SCHEMBL13650035 | 0.81 | — | — | |
| SCHEMBL13726434 | 0.79 | — | — | |
| SCHEMBL13650031 | 0.76 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7534771-B2 | Tricyclic-nucleoside prodrugs for treating viral infections | SMITHKLINE BEECHAM CORPORATION (US) | 2009-05-19 | — | — | US | disclosed |